Literature DB >> 17027934

MCH-containing neurons in the hypothalamus of the cat: searching for a role in the control of sleep and wakefulness.

Pablo Torterolo1, Sharon Sampogna, Francisco R Morales, Michael H Chase.   

Abstract

Neurons that utilize melanin-concentrating hormone (MCH) and others that employ hypocretin as neurotransmitter are located in the hypothalamus and project diffusely throughout the CNS, including areas that participate in the generation and maintenance of the states of sleep and wakefulness. In the present report, immunohistochemical methods were employed to examine the distribution of MCHergic and hypocretinergic neurons. In order to test the hypothesis that the MCHergic system is capable of influencing specific behavioral states, we studied Fos immunoreactivity in MCH-containing neurons during (1) quiet wakefulness, (2) active wakefulness with motor activity, (3) active wakefulness without motor activity, (4) quiet sleep and (5) active sleep induced by carbachol (AS-carbachol). We determined that MCHergic neuronal somata in the cat are intermingled with hypocretinergic neurons in the dorsal and lateral hypothalamus, principally in the tuberal and tuberomammillary regions; however, hypocretinergic neurons extended more in the anterior-posterior axis than MCHergic neurons. Axosomatic and axodendritic contacts were common between these neurons. In contrast to hypocretinergic neurons, which are known to be active during motor activity and AS-carbachol, Fos immunoreactivity was not observed in MCH-containing neurons in conjunction with any of the preceding behavioral conditions. Non-MCHergic, non-hypocretinergic neurons that expressed c-fos during active wakefulness with motor activity were intermingled with MCH and hypocretin-containing neurons, suggesting that these neurons are related to some aspect of motor function. Further studies are required to elucidate the functional sequela of the interactions between MCHergic and hypocretinergic neurons and the phenotype of the other neurons that were active during motor activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027934      PMCID: PMC1802635          DOI: 10.1016/j.brainres.2006.08.100

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  56 in total

1.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

2.  Decreased spontaneous locomotor activity in the rat induced by hypothalamic lesions.

Authors:  W E GLADFELTER; J R BROBECK
Journal:  Am J Physiol       Date:  1962-11

3.  Midbrain areas required for locomotion initiated by electrical stimulation of the lateral hypothalamus in the anesthetized rat.

Authors:  D I Levy; H M Sinnamon
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

4.  Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats.

Authors:  A Shekhar; J A DiMicco
Journal:  Neuropharmacology       Date:  1987-05       Impact factor: 5.250

5.  Nitric oxide as an anterograde neurotransmitter in the trigeminal motor pool.

Authors:  Verónica Abudara; Adriana Fernández Alvarez; Michael H Chase; Francisco R Morales
Journal:  J Neurophysiol       Date:  2002-07       Impact factor: 2.714

6.  Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system.

Authors:  Ying Li; Xiao Bing Gao; Takeshi Sakurai; Anthony N van den Pol
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

7.  Differential regulation of melanin-concentrating hormone gene expression in distinct hypothalamic areas under osmotic stimulation in rat.

Authors:  F Presse; J L Nahon
Journal:  Neuroscience       Date:  1993-08       Impact factor: 3.590

8.  Locomotor stepping elicited by electrical stimulation of the lateral hypothalamus requires an ipsilateral descending pathway.

Authors:  H M Sinnamon; S H Lee; D B Adams; C K Stopford
Journal:  Physiol Behav       Date:  1984-08

9.  Locomotion elicited by lateral hypothalamic stimulation in the anesthetized rat does not require the dorsal midbrain.

Authors:  H M Sinnamon; C K Stopford
Journal:  Brain Res       Date:  1987-01-27       Impact factor: 3.252

10.  A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep.

Authors:  Laure Verret; Romain Goutagny; Patrice Fort; Laurène Cagnon; Denise Salvert; Lucienne Léger; Romuald Boissard; Paul Salin; Christelle Peyron; Pierre-Hervé Luppi
Journal:  BMC Neurosci       Date:  2003-09-09       Impact factor: 3.288

View more
  21 in total

1.  Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle.

Authors:  Oum Kaltoum Hassani; Maan Gee Lee; Barbara E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

Review 2.  Current and emerging options for the drug treatment of narcolepsy.

Authors:  Alberto K De la Herrán-Arita; Fabio García-García
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

3.  A restricted parabrachial pontine region is active during non-rapid eye movement sleep.

Authors:  P Torterolo; S Sampogna; M H Chase
Journal:  Neuroscience       Date:  2011-06-15       Impact factor: 3.590

4.  Distribution of hypothalamic neurons with orexin (hypocretin) or melanin concentrating hormone (MCH) immunoreactivity and multisynaptic connections with diaphragm motoneurons.

Authors:  Varun M Badami; Cory D Rice; James H Lois; Jayesh Madrecha; Bill J Yates
Journal:  Brain Res       Date:  2010-02-06       Impact factor: 3.252

5.  Hypocretin-1 (orexin A) prevents the effects of hypoxia/hypercapnia and enhances the GABAergic pathway from the lateral paragigantocellular nucleus to cardiac vagal neurons in the nucleus ambiguus.

Authors:  O Dergacheva; K Philbin; R Bateman; D Mendelowitz
Journal:  Neuroscience       Date:  2010-12-04       Impact factor: 3.590

6.  State-dependent control of lumbar motoneurons by the hypocretinergic system.

Authors:  Jack Yamuy; Simon J Fung; Mingchu Xi; Michael H Chase
Journal:  Exp Neurol       Date:  2009-12-03       Impact factor: 5.330

7.  Orexin-A inputs onto visuomotor cell groups in the monkey brainstem.

Authors:  S Schreyer; J A Büttner-Ennever; X Tang; M J Mustari; A K E Horn
Journal:  Neuroscience       Date:  2009-08-22       Impact factor: 3.590

8.  Comparison of melanin-concentrating hormone and hypocretin/orexin peptide expression patterns in a current parceling scheme of the lateral hypothalamic zone.

Authors:  Joel D Hahn
Journal:  Neurosci Lett       Date:  2009-10-20       Impact factor: 3.046

9.  Hypocretinergic and non-hypocretinergic projections from the hypothalamus to the REM sleep executive area of the pons.

Authors:  Pablo Torterolo; Sharon Sampogna; Michael H Chase
Journal:  Brain Res       Date:  2012-10-30       Impact factor: 3.252

10.  Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis.

Authors:  A Nuñez; M L Rodrigo-Angulo; I De Andrés; M Garzón
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.